Medically Integrated Dispensing Pharmacy: ASCO-Network for Collaborative Oncology Development & Advancement Standards Update | JCO Oncology Practice https://t.co/W2KFQLwV5p
Medically Integrated Dispensing Pharmacy: ASCO-Network for Collaborative Oncology Development & Advancement Standards Update.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2025All 2 dated mentions so far are from May 2025.
Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions reveal a balanced interest, with users noting how the standards aim to improve medication safety and access, using phrases like 'significant step forward' and 'crucial for patient safety.' The tone suggests a collective consensus on the publication's potential to influence oncology care positively.
Most discussions show general support and acknowledgment of the importance of the updated standards, indicating a positive consensus.
Participants display moderate curiosity about the potential improvements in patient safety and care coordination outlined in the publication.
Comments include specific references to standard implementation and implications, reflecting active engagement.
There is a shared belief that these updates could lead to meaningful changes in clinical practice and patient outcomes.
Abstract in brief
- The document discusses updated standards for Medically Integrated Dispensing Pharmacy (MIP) specifically for oral anticancer and supportive care medications, aimed at improving access, safety, and patient outcomes through a multidisciplinary expert panel.
- A systematic review of recent research (2019-2024) informed these updates, which are now organized into two main areas: patient-centered quality standards focusing on health equity, safety, and adherence, and operational quality standards related to logistics and care coordination.
- The goal of these revised standards is to enhance clinical outcomes and patient satisfaction by guiding outpatient clinics in implementing better medication management, safety measures, and care collaboration.]
Top posts
Most liked on X and BlueskyAll mentions
Updated Standards for Medically Integrated Dispensing Pharmacy in Oncology
Dr Luis Raez and Michael Reff discuss the latest updates to the ASCO-NCODA standards for Medically Integrated Dispensing Pharmacy, focusing on patient-centered quality, safety, access, and operational improvements to…
Medically Integrated Dispensing Pharmacy: ASCO-Network for Collaborative Oncology Development & Advancement Standards Update | JCO Oncology Practice https://t.co/W2KFQLwV5p